Back to search

Article

Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in nonalcoholic fatty liver disease

2021-03-22

Abstract excerpt

<h4>Background & Aims</h4> Nonalcoholic fatty liver disease (NAFLD) poses an impending clinical burden. Genome-wide association studies have revealed a limited contribution of genomic variants to the disease, requiring alternative but robust approaches to identify disease-associated variants and genes. We carried out a disease-specific expression quantitative trait loci (eQTL) screen to identify novel genetic fac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19f3e4fa-e91b-50ea-82c8-f14ee20bd8db
DOI
10.1101/2021.03.22.436368
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in nonalcoholic fatty liver diseaseDOI 10.1101/2021.03.22.436368
Select a neighboring publication to make it the new centre.